Rifat Hamoudi is a professor in molecular, cellular, and
computational medicine within the Department of Clinical Sciences, College of
Medicine at the University of Sharjah, Sharjah, United Arab Emirates. He is a
multi- and inter-disciplinary researcher with a deep background and work
experience that spans the fields of medicine, engineering, and computer
science. He has three different MSc degrees in biochemistry and molecular
biology, electronic and medical engineering, and computer science. He has a Ph.D.
from the University of Cambridge in pathology and immunology. He is an honorary
associate professor in the Division of Surgery and Interventional Science at
UCL, United Kingdom. He has research experience in cancer genetics, molecular
and cellular pathology, and software engineering projects and was involved in
the design and analysis of more than 150 pieces of scientific research,
including phase I clinical trials published in high-impact journals. His
interests include Computational Medicine, Oncology, Pathology, Bioinformatics,
Mathematical Modelling of non-linear processes, Molecular and Cellular
Immunology, Hematology, and Personalised Medicine.
Rifat Hamoudi is a professor in molecular, cellular, and
computational medicine within the Department of Clinical Sciences, College of
Medicine at the University of Sharjah, Sharjah, United Arab Emirates. He is a
multi- and inter-disciplinary researcher with a deep background and work
experience that spans the fields of medicine, engineering, and computer
science. He has three different MSc degrees in biochemistry and molecular
biology, electronic and medical engineering, and computer science. He has a Ph.D.
from the University of Cambridge in pathology and immunology. He is an honorary
associate professor in the Division of Surgery and Interventional Science at
UCL, United Kingdom. He has research experience in cancer genetics, molecular
and cellular pathology, and software engineering projects and was involved in
the design and analysis of more than 150 pieces of scientific research,
including phase I clinical trials published in high-impact journals. His
interests include Computational Medicine, Oncology, Pathology, Bioinformatics,
Mathematical Modelling of non-linear processes, Molecular and Cellular
Immunology, Hematology, and Personalised Medicine.